LTRN
Lantern Pharma Inc.
-0.15 (-7.92%)1.78USD139K成交股數22.7M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.8M | 1.7M | 2.7M | 2.4M | 3.1M | 3.3M | 3.7M | 3.9M | 4.3M | 3.6M | 2.2M | 3.6M |
| 銷售管理費用 | 1.7M | 1.7M | 1.5M | 1.9M | 1.6M | 1.5M | 1.5M | 1.5M | 1.5M | 1.3M | 1.3M | 1.6M |
| 營業利益 | −3.5M-25% | −3.4M-29% | −4.2M-19% | −4.3M-20% | −4.7M-19% | −4.8M-2% | −5.2M+47% | −5.4M+4% | −5.7M | −4.9M | −3.5M | −5.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −7.1M+63% | −3.3M-27% | −4.1M-10% | −4.2M-16% | −4.3M-20% | −4.5M+8% | −4.5M+43% | −5.0M+4% | −5.4M | −4.2M | −3.2M | −4.7M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.57+42% | -0.30-29% | -0.36-14% | -0.39-15% | -0.40-22% | -0.42+11% | -0.42+45% | -0.46+5% | -0.51 | -0.38 | -0.29 | -0.44 |
| 稀釋股數 | 12.4M | 11.3M | 10.9M | 10.8M | 10.8M | 10.8M | 10.8M | 10.8M | 10.7M | 10.8M | 10.9M | 10.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 6.7M | 4.9M | 4.4M | 8.4M | 6.1M | 6.4M | 8.1M | 13.0M | 18.4M | 21.9M | 25.6M | 28.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 8.6M | 7.2M | 11.0M | 13.6M | 17.4M | 21.1M | 30.3M | 35.6M | 39.7M | 43.6M | 47.8M | 51.4M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 11.8M | 3.8M | 4.5M | 4.0M | 4.9M | 4.3M | 3.7M | 4.7M | 4.0M | 2.7M | 2.4M | 3.2M |
| 股東權益 | −3.2M | 3.4M | 6.5M | 9.6M | 12.5M | 16.8M | 26.6M | 30.9M | 35.8M | 40.9M | 45.4M | 48.3M |
| 負債比 | 137.4% | 52.3% | 40.8% | 29.6% | 28.1% | 20.5% | 12.2% | 13.1% | 10.0% | 6.3% | 4.9% | 6.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.8M-14% | – | – | – | −4.4M | – | – | −3.1M | – | – | – |
| 資本支出 | – | – | – | – | – | 1K | – | – | 2K | – | – | – |
| 自由現金流 | – | – | – | – | – | −4.4M | – | – | −3.1M | – | – | – |
| 折舊攤銷 | – | 4K | – | – | – | 5K | – | – | 4K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −17.1M | –% | -1.57 | −15.7M |
| FY2024 | – | – | −20.8M | –% | -1.93 | −17.8M |
| FY2023 | – | – | −16.0M | –% | -1.47 | −14.4M |
| FY2022 | – | – | −14.3M | –% | -1.31 | −12.8M |
| FY2021 | – | – | −12.4M | –% | -1.13 | −10.6M |
| FY2020 | – | – | −5.9M | –% | -1.37 | – |
| FY2019 | – | – | −2.4M | –% | -1.23 | – |